HomeFile

File

ESC 2022 | REVIVED-BCIS2

The REVIVED-BCI2 included 700 patients with ejection fraction ≤35% with extended coronary artery disease and plausible PCI. Patients...

Adherence to P2Y12 Inhibitors in Acute Coronary Syndrome: Prognosis

Non-adherence to medication in patients with acute coronary syndrome (ACS) remains to be solved; the use of...

ESC 2022 | SECURE Trial

This study, presented by Dr. Valentin Fuster, focused on the importance of medical treatment compliance, initially showing...

ESC 2022 | TIME STUDY

The TIME study, presented by Dr. Thomas MacDonald, is a randomized study of over 21,000 patients with...

TAVR in Bicuspid Patients: Are Outcomes the Same in Men and Women?

Bicuspid aortic valve stenosis (BAV) has not yet been analyzed in large, randomized studies, and TAVR in...

Aspiration Thrombectomy in Acute Coronary Syndrome: Is the Japanese Perspective a Strategy to Emulate?

Aspiration thrombectomy (AT) in patients with high thrombotic burden could pathophysiologically reduce thrombus burden, decrease distal embolization,...

Optimization by IVUS after FFR Guided PCI: Are There Clinical Benefits for Patients?

Percutaneous coronary interventions have improved during the last decade with 15% rate of target vessel failure (TVF)...